N@N

Matt Miksic Maintained (ZBH) at Sell with Increased Target to $130 on, Feb 12th, 2024

Matt Miksic of Barclays, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Sell with Increased Target from $120 to $130 on, Feb 12th, 2024.

Matt has made no other calls on ZBH in the last 4 months.

There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 5 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Richard Newitter of "Truist Securities" Maintained at Hold with Increased Target to $135 on, Friday, February 9th, 2024
• Robbie Marcus of "JP Morgan" Maintained at Hold with Increased Target to $125 on, Friday, February 9th, 2024
• Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $125 on, Thursday, January 4th, 2024
• Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $125 on, Monday, December 4th, 2023
• Jason Wittes of "Roth MKM" Initiated at Hold and Held Target at $120 on, Friday, October 20th, 2023

These are the ratings of the 3 analyists that currently disagree with Matt

---

• Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $140 on, Friday, February 9th, 2024
• Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $137 on, Wednesday, January 3rd, 2024
• David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $140 on, Monday, November 13th, 2023

Contributing Sources

---